Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

563 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.
Baertsch MA, Leber MF, Bossow S, Singh M, Engeland CE, Albert J, Grossardt C, Jäger D, von Kalle C, Ungerechts G. Baertsch MA, et al. Among authors: jager d. Cancer Gene Ther. 2014 Sep;21(9):373-80. doi: 10.1038/cgt.2014.40. Epub 2014 Aug 22. Cancer Gene Ther. 2014. PMID: 25145311
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.
Engeland CE, Grossardt C, Veinalde R, Bossow S, Lutz D, Kaufmann JK, Shevchenko I, Umansky V, Nettelbeck DM, Weichert W, Jäger D, von Kalle C, Ungerechts G. Engeland CE, et al. Among authors: jager d. Mol Ther. 2014 Nov;22(11):1949-59. doi: 10.1038/mt.2014.160. Epub 2014 Aug 26. Mol Ther. 2014. PMID: 25156126 Free PMC article.
A Tupaia paramyxovirus vector system for targeting and transgene expression.
Engeland CE, Bossow S, Hudacek AW, Hoyler B, Förster J, Veinalde R, Jäger D, Cattaneo R, Ungerechts G, Springfeld C. Engeland CE, et al. Among authors: jager d. J Gen Virol. 2017 Sep;98(9):2248-2257. doi: 10.1099/jgv.0.000887. Epub 2017 Sep 8. J Gen Virol. 2017. PMID: 28809150
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.
Hajda J, Lehmann M, Krebs O, Kieser M, Geletneky K, Jäger D, Dahm M, Huber B, Schöning T, Sedlaczek O, Stenzinger A, Halama N, Daniel V, Leuchs B, Angelova A, Rommelaere J, Engeland CE, Springfeld C, Ungerechts G. Hajda J, et al. Among authors: jager d. BMC Cancer. 2017 Aug 29;17(1):576. doi: 10.1186/s12885-017-3604-y. BMC Cancer. 2017. PMID: 28851316 Free PMC article. Clinical Trial.
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites.
Leber MF, Baertsch MA, Anker SC, Henkel L, Singh HM, Bossow S, Engeland CE, Barkley R, Hoyler B, Albert J, Springfeld C, Jäger D, von Kalle C, Ungerechts G. Leber MF, et al. Among authors: jager d. Mol Ther Oncolytics. 2018 Apr 12;9:30-40. doi: 10.1016/j.omto.2018.04.002. eCollection 2018 Jun 29. Mol Ther Oncolytics. 2018. PMID: 29988512 Free PMC article.
Measles Vaccines Designed for Enhanced CD8+ T Cell Activation.
Busch E, Kubon KD, Mayer JKM, Pidelaserra-Martí G, Albert J, Hoyler B, Heidbuechel JPW, Stephenson KB, Lichty BD, Osen W, Eichmüller SB, Jäger D, Ungerechts G, Engeland CE. Busch E, et al. Among authors: jager d. Viruses. 2020 Feb 21;12(2):242. doi: 10.3390/v12020242. Viruses. 2020. PMID: 32098134 Free PMC article.
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer.
Singh HM, Leber MF, Bossow S, Engeland CE, Dessila J, Grossardt C, Zaoui K, Bell JC, Jäger D, von Kalle C, Ungerechts G. Singh HM, et al. Among authors: jager d. Mol Ther Oncolytics. 2021 May 5;21:340-355. doi: 10.1016/j.omto.2021.04.015. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 34141871 Free PMC article.
563 results